The aim of this study was to obtain insights into the relationship between coping self-efficacy and psychological morbidity in newly found BRCA1/2 PV carriers, such as clinical anxiety, depression, and post-traumatic stress. This evidence concerns the gene BRCA1 and depressive symptom measurement.